menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Communicating Drug Safety Messages

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Comments
  • Overview

    Pharmacists have consistently partnered with FDA on drug safety. Since pharmacists are the most accessible health care professional, they play a key role in educating and discussing FDA's drug safety messages with patients. Moreover, pharmacists are the main reporters of adverse events, incidents of product quality problems, errors in use, and therapeutic failures or inequivalence to FDA's MedWatch program.

    Now, the Internet, social media, and emerging technologies allow FDA to be more transparent and to communicate directly with pharmacists, healthcare professionals and patients in real time. It's essential for pharmacists to stay informed of the latest drug safety information and FDA's new social media tools make it easy.

    Learn more about the FDA Drug Info Rounds...

Facebook Comments

Recommended
Details
Comments
  • Overview

    Pharmacists have consistently partnered with FDA on drug safety. Since pharmacists are the most accessible health care professional, they play a key role in educating and discussing FDA's drug safety messages with patients. Moreover, pharmacists are the main reporters of adverse events, incidents of product quality problems, errors in use, and therapeutic failures or inequivalence to FDA's MedWatch program.

    Now, the Internet, social media, and emerging technologies allow FDA to be more transparent and to communicate directly with pharmacists, healthcare professionals and patients in real time. It's essential for pharmacists to stay informed of the latest drug safety information and FDA's new social media tools make it easy.

    Learn more about the FDA Drug Info Rounds...

Facebook Comments

Schedule28 Mar 2024